Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

May 2020| TBR332B| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; Abbott Laboratories Inc; Daiichi Sankyo Company

Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Musculoskeletal Disorders Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider musculoskeletal disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The musculoskeletal disorders drugs market section of the report gives context. It compares the musculoskeletal disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Scope

Markets Covered:
1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; Abbott Laboratories Inc; Daiichi Sankyo Company

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 4 : Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 5 : Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11 : Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Table 12 : Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global
  • Table 13 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 14 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 15 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Table 17 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
  • Table 18 : Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 19 : China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 20 : China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 21 : Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 22 : Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 23 : Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 24 : India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 25 : India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 26 : Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 27 : Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 28 : Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 29 : Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 30 : Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 31 : New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 32 : Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 33 : Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 34 : South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 35 : Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 36 : Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 37 : Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 38 : Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 39 : Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 40 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
  • Table 41 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
  • Table 42 : Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 43 : Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 44 : Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 45 : Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 46 : Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 47 : France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 48 : France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 49 : Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 50 : Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 51 : Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 52 : Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 53 : Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 54 : Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 55 : Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 56 : Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 57 : Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 58 : Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 59 : UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 60 : UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 61 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 62 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 63 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 64 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Table 65 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
  • Table 66 : Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 67 : Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 68 : Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 69 : Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 70 : Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 71 : Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 72 : North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 73 : North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 74 : North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 75 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
  • Table 76 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
  • Table 77 : North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 78 : Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 79 : Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 80 : USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 81 : USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 82 : South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 83 : South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 84 : South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 85 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
  • Table 86 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
  • Table 87 : South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 88 : Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 89 : Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 90 : Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 91 : Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 92 : Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 93 : Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 94 : Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 95 : Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 96 : Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 97 : Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 98 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
  • Table 99 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
  • Table 100 : Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 101 : Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 102 : Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 103 : Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 104 : UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 105 : Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 106 : Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 107 : Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 108 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
  • Table 109 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
  • Table 110 : Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 111 : Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 112 : Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 113 : South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 114 : F. Hoffmann-La Roche Ltd Financial Performance
  • Table 115 : GlaxosmithKline Plc Financial Performance
  • Table 116 : Pfizer Inc Financial Performance
  • Table 117 : Abbott Laboratories Inc Financial Performance
  • Table 118 : Daiichi Sankyo Company Financial Performance
  • Table 119 : Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 120 : Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 121 : Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 122 : Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 123 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
  • Table 124 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
  • Table 125 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 4 : Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 5 : Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11 : Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Figure 12 : Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global
  • Figure 13 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 14 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 15 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Figure 17 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
  • Figure 18 : Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 19 : China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 20 : China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 21 : Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 22 : Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 23 : Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 24 : India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 25 : India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 26 : Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 27 : Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 28 : Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 29 : Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 30 : Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 31 : New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 32 : Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 33 : Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 34 : South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 35 : Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 36 : Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 37 : Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 38 : Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 39 : Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 40 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
  • Figure 41 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
  • Figure 42 : Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 43 : Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 44 : Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 45 : Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 46 : Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 47 : France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 48 : France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 49 : Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 50 : Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 51 : Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 52 : Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 53 : Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 54 : Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 55 : Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 56 : Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 57 : Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 58 : Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 59 : UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 60 : UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 61 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 62 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 63 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 64 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Figure 65 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
  • Figure 66 : Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 67 : Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 68 : Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 69 : Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 70 : Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 71 : Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 72 : North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 73 : North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 74 : North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 75 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
  • Figure 76 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
  • Figure 77 : North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 78 : Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 79 : Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 80 : USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 81 : USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 82 : South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 83 : South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 84 : South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 85 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
  • Figure 86 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
  • Figure 87 : South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 88 : Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 89 : Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 90 : Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 91 : Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 92 : Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 93 : Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 94 : Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 95 : Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 96 : Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 97 : Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 98 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
  • Figure 99 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
  • Figure 100 : Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 101 : Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 102 : Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 103 : Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 104 : UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 105 : Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 106 : Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 107 : Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 108 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
  • Figure 109 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
  • Figure 110 : Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 111 : Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 112 : Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 113 : South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 114 : F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 115 : GlaxosmithKline Plc Financial Performance
  • Figure 116 : Pfizer Inc Financial Performance
  • Figure 117 : Abbott Laboratories Inc Financial Performance
  • Figure 118 : Daiichi Sankyo Company Financial Performance
  • Figure 119 : Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120 : Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 121 : Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 122 : Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 123 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
  • Figure 124 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
  • Figure 125 : Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report